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EWU Department of Biology
Statement of purpose

• To investigate the effects of human
immunodeficiency virus (HIV) on the health of
pregnant mothers and their babies, as opposed to
non-pregnant hosts.
• To investigate the transmission modes of HIV from
Mother to Child (MTC), as well as the role the
placenta plays in transmission and protection
Background and Significance

• Sexually transmitted infections (STIs) have major
clinical significance around the world and are a topic
that is actively researched. Specifically, human
immunodeficiency virus (HIV) is a well-known STI that
has been studied extensively and will be the focus of
this review.
HIV Transmission:
• Vertical transmission in utero (during pregnancy),
birth (delivery), and breast feeding.
• Direct transmission to Monocytes or T Cells
through lesions in the placental barrier
• Transcytosis across trophoblast layer or infected
cells
• Enters as maternal antibody complex
• During either late or early pregnancy is most likely
• Maternal viral load & antibodies play a role in
transmission to infant
Treatments & Placental Protection:
• Anti-retroviral treatments helps prevent vertical
transmission of HIV
• Placental macrophages play protective role,
although their function is not well understood.
• Even with the increasing success of antivirals,
pregnant women who are HIV-positive have a
higher incidence of preterm and underweight
babies.

Methods

• Accumulation, filtration, and analysis of scientific reviews using a bank of keywords relevant to the proposed study
(Figure 1).
• Input keywords into Web of Science search engine
• Keywords were added or exchanged until there was a return of 20-40 relevant articles
• Final keywords were “pregnant, HIV, transmission, placenta” with a return of 26 accessible reviews.
• Selected articles were then added to a database, Mendeley, accessed by all the group members.
• Articles were read by all group members and filtered based on inclusion and exclusion criteria
• Articles were included based on if they discussed the topics of placental transmission of HIV, detrimental effects to
mother and child, as well as some treatment methods
• Articles were not excluded based on age of an article
• Post filtration, this project had 16 included review articles
• Group members then read the included articles in full, compiling relevant data and information into a shared database
amongst group members.
• Final data included information on the types of adverse effects found in mothers and babies, as well as the mode of
transmission between mother and babies focusing on placental transmission, possible birth defects, occurrence of
infection in pregnancy, and health of infected pregnant mothers versus health of non-pregnant hosts.
Figures

• To guide clinical practice for treatment and
prevention of HIV effects in women and fetuses
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• HIV positive pregnant women are at increased risk for
negative perinatal outcomes, including low birth weight
• High levels of certain cytokines create a "placental
barrier" effect by producing a protective environment
that can control the spread of HIV in the placenta
• Some studies show that vitamin A deficiency can
weaken the placental epithelium which increases risk
of transmission to the fetus
• Anti-viral drugs administered to the mother can
passively diffuse through the placenta, but the
concentration of the drug as well as chemical
properties such as polarity can affect diffusibility
• Hofbauer cells (placental macrophages) are a possible
mode of entry for HIV
• In rare cases, mitochondrial toxicity syndromes can
occur with antiretroviral treatment of combining multiple
nucleoside reverse transcriptase inhibitors
• HIV infected macrophages create an inflamed uterine
environment which may lead to negative perinatal
outcomes
Conclusions

• HIV is a serious infection linked with debilitating
conditions and birth defects

Figure 1. Flowchart of methods. This flowchart is modeled off the Tawfik Step-by-Step Review and has been formatted to be applicable to this
research topic. It illustrates a brief overview of the methodology used to collect and synthesize information.

Objective

• The main objective of this project is to create a
systematic review on the impacts of HIV on
pregnant women, transmission from mother to
child, and how the placenta plays a role in
protection of the fetus.

Results & Discussion

• The placenta acts as a natural barrier, but some
infections can still cross it, including HIV
• Antiretrovirals are an important part of HIV treatment
in pregnant women
• Shown to lower mother to child transmission from
20% to <2%
• Can pass through placenta to provide fetus with
improved defense mechanisms
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